Knihu momentálně nemáme skladem
Parametry
- 264 stránek
- 10 hodin čtení
Více o knize
The book presents a groundbreaking strategy for complete cancer treatment through two novel drug compounds, PT162 and PT167, developed by Andreas J. Kesel. These drugs target the Warburg effect, exploiting cancer's reliance on glycolysis due to mitochondrial dysfunction. Both compounds demonstrate significant efficacy in vitro against 60 cancer cell lines, inducing apoptosis by reactivating p53 and disrupting cyclin D1 regulation. The book details the chemistry behind these compounds and their apoptotic mechanisms, offering hope for innovative cancer therapies.
Nákup knihy
THE POTENTIAL HEALING OF CANCER WITH P53 (RE)ACTIVATORS, Andreas Johannes Kesel
- Jazyk
- Rok vydání
- 2023
- product-detail.submit-box.info.binding
- (pevná)
Jakmile se objeví, pošleme e-mail.
Doručení
Platební metody
Nikdo zatím neohodnotil.
- Titul
- THE POTENTIAL HEALING OF CANCER WITH P53 (RE)ACTIVATORS
- Podtitul
- TWO NEW DRUGS EXPLOITING CANCER'S WARBURG EFFECT
- Jazyk
- anglicky
- Autoři
- Andreas Johannes Kesel
- Vydavatel
- tredition
- Rok vydání
- 2023
- Vazba
- pevná
- Počet stran
- 264
- ISBN10
- 3384003128
- ISBN13
- 9783384003126
- Série
- Štítky
- Zdraví & Lékařství, Příroda, Přírodní vědy, Lékařská tématika, Chemie, Příroda, zvířata, Farmakologie, Biochemie, Onkologie, Organická chemie, Molekulární biologie, Biologie člověka, Anorganická chemie, Chemoterapie, Farmakoterapie
- Anotace
- The book presents a groundbreaking strategy for complete cancer treatment through two novel drug compounds, PT162 and PT167, developed by Andreas J. Kesel. These drugs target the Warburg effect, exploiting cancer's reliance on glycolysis due to mitochondrial dysfunction. Both compounds demonstrate significant efficacy in vitro against 60 cancer cell lines, inducing apoptosis by reactivating p53 and disrupting cyclin D1 regulation. The book details the chemistry behind these compounds and their apoptotic mechanisms, offering hope for innovative cancer therapies.